The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Abstract
The amyloid β protein has been identified as an important component of both cerebrovascular amyloid and amyloid plaques of Alzheimer's disease and Down syndrome. A complementary DNA for the β protein suggests that it derives from a larger protein expressed in a variety of tissues. Overexpression of the gene in brain tissue from fetuses with Down syndrome (trisomy 21) can be explained by dosage since the locus encoding the β protein maps to chromosome 21. Regional localization of this gene by both physical and genetic mapping places it in the vicinity of the genetic defect causing the inherited form of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, sequence differences between mice and humans include 3 amino acids within the Aβ sequence (R5G, Y10F and H13R)[155, 174].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [155]
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
Yanisch-Perron, C., Vieira, J., & Messing, J. W. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 14,909
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 13,943
Construction of a genetic linkage map in man using restriction fragment length polymorphisms.
Botstein, D., White, R. L., Skolnick, M. H., & Davis, R. W. (1980) · Europe PMC (PubMed Central) · Cited by 8,327
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Efficient isolation of genes by using antibody probes.
Young, R. A., & Davis, R. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1194 · Cited by 2,036
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Flagged first, then by citations
Research works printed but not linked: 5
- BRADLEY, C.M., TRISOMY 21 1: 41 (1986).
- GLENNER, G, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 107: 218 (1983).
- GLENNER, G, BRANBURY REPORT 15: 137 (1983).
- NEIBUHR, E, HUMANGENETIK 21: 99 (1974).
- Young, R. A., Proceedings of the National Academy of Sciences of the United States of America 80: 1194 (1983).
Cited by
Sorted by citations
Items 201–300 of 1,000
Roßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 195
Tanzi, R. E., Vaula, G., Romano, D., Mortilla, M., Huang, T., Tupler, R. G., Wasco, W., Hyman, B. T., Haines, J. L., & Jenkins, B. (1992) · PubMed · Cited by 195
Self-citationMaggio, J. E., Stimson, E. R., Ghilardi, J. R., Allen, C. J., Dahl, C. E., Whitcomb, D. C., Vigna, S. R., Vinters, H. V., Labenski, M. E., & Mantyh, P. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5462 · Cited by 195
Molecular mechanisms of neuropathological changes in Alzheimer’s disease: a review
Šerý, O., Povová, J., Mı́šek, I., Pešák, L., & Janout, V. (2013) · Folia Neuropathologica · doi:10.5114/fn.2013.34190 · Cited by 198
Weggen, S., & Beher, D. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt107 · Cited by 192
Prions and Neurodegenerative Diseases
Epstein, F. H., & Prusiner, S. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172505 · Cited by 192
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 192
Zhang, C. M., Browne, A., Child, D. D., & Tanzi, R. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133520 · Cited by 191
Self-citationQiu, W. W. Q., Ferreira, A., Miller, C., Koo, E., & Selkoe, D. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02157.1995 · Cited by 193
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
Rommy von Bernhardi, M., & Eugenín, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 193
Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques
Ginsberg, S. D., Crino, P. B., Lee, V. M. ‐., Eberwine, J. H., & Trojanowski, J. Q. (1997) · Annals of Neurology · doi:10.1002/ana.410410211 · Cited by 188
Tomita, S., Kirino, Y., & Suzuki, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6277 · Cited by 188
Understanding the Amyloid Hypothesis in Alzheimer’s Disease
Paroni, G., Bisceglia, P., & Seripa, D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180802 · Cited by 194
The β-Secretase, BACE: A Prime Drug Target for Alzheimer's Disease
Vassar, R. J. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:157 · Cited by 188
Cohen, M. L., Golde, T. E., Usiak, M., Younkin, L. H., & Younkin, S. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1227 · Cited by 186
Marcinkiewicz, M. M., & Seidah, N. G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752133.x · Cited by 190
Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior
Picciotto, M. R., & Wickman, K. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1131 · Cited by 189
Biology of Aβ Amyloid in Alzheimer's Disease
Wisniewski, T., Ghiso, J., & Frangione, B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0147 · Cited by 134
β-Amyloid protein promotes neuritic branching in hippocampal cultures
Whitson, J. S., Glabe, C. G., Shintani, E., Abcar, A. C., & Cotman, C. W. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90867-9 · Cited by 185
Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?
Carrillo‐Mora, P., Luna, R., & Colín-Barenque, L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/795375 · Cited by 187
Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 187
Neuritic Plaque Amyloid in Alzheimer's Disease Is Highly Racemized
Shapira, R., Austin, G. E., & Mirra, S. S. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb13231.x · Cited by 184
Buxbaum, J. D., Ruefli, A. A., Parker, C. A., Cypess, A. M., & Greengard, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4489 · Cited by 184
Role of microglia in senile plaque formation
Mackenzie, I. R. A., Hao, C., & Munoz, D. G. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00092-s · Cited by 183
Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein.
Davis, J., & Nostrand, W. E. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2996 · Cited by 182
Joachim, C. L., Duffy, L. K., Morris, J. H., & Selkoe, D. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)90673-7 · Cited by 180
Güntert, A., Döbeli, H., & Bohrmann, B. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.027 · Cited by 180
Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
Malik, B. R., Maddison, D. C., Smith, G. A., & Peters, O. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0504-x · Cited by 187
The Genetics of Alzheimer Disease
Blacker, D., & Tanzi, R. E. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.294 · Cited by 185
Self-citationQuantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers
Smailovic, U., Koenig, T., Kåreholt, I., Andersson, T., Kramberger, M. G., Winblad, B., & Jelic, V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.005 · Cited by 177
Verdile, G. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.028 · Cited by 181
Aβ Toxicity in Alzheimer's Disease
Cavallucci, V., D’Amelio, M., & Cecconi, F. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8251-3 · Cited by 179
Genetic dissection of Alzheimer disease, a heterogeneous disorder.
Schellenberg, G. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8552 · Cited by 178
Higgins, G. A., Lewis, D. A., Bahmanyar, S., Goldgaber, D., Gajdusek, D. C., Young, W. G., Morrison, J. H., & Wilson, M. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1297 · Cited by 177
Proteoglycan-mediated Inhibition of Aβ Proteolysis
Gupta‐Bansal, R., Frederickson, R. C. A., & Brunden, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18666 · Cited by 177
Cataldo, A. M., Thayer, C. Y., Bird, E. D., Wheelock, T. R., & Nixon, R. A. (1990) · Brain Research · doi:10.1016/0006-8993(90)90456-l · Cited by 176
Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis.
Korenberg, J. R., Bradley, C. M., & Distèche, C. M. (1992) · Europe PMC (PubMed Central) · Cited by 175
Hung, A. Y., Koo, E. H., Haass, C., & Selkoe, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9439 · Cited by 175
Theoretical models of the ion channel structure of amyloid beta-protein
Durell, S. R., Guy, H. R., Arispe, N. J., Rojas, E., & Pollard, H. B. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80717-9 · Cited by 177
Mesulam, M. M., Geula, C., & Morán, M. A. (1987) · Annals of Neurology · doi:10.1002/ana.410220603 · Cited by 175
Rao, V. N., Papas, T. S., & Reddy, E. S. P. (1987) · Science · doi:10.1126/science.3299708 · Cited by 177
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
Cras, P. P., Kawai, M., Siedlak, S. L., Mulvihill, P., Gambetti, P. L., Lowery, D. E., Gonzalez‐DeWhitt, P. A., Greenberg, B., & Perry, G. L. (1990) · Europe PMC (PubMed Central) · Cited by 174
Gene Dosage of the Amyloid β Precursor Protein in Alzheimer's Disease
Podlisny, M. B., Lee, G. S., & Selkoe, D. J. (1987) · Science · doi:10.1126/science.2960019 · Cited by 174
Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease
Wang, X., Zhou, X., Li, G., Zhang, Y., Wu, Y., & Song, W. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00294 · Cited by 183
Bayer, T. A., Wirths, O., Majtényi, K., Hartmann, T., Multhaup, G., Beyreuther, K. T., & Czech, C. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00376.x · Cited by 174
Cotman, S. L., Halfter, W. M., & Cole, G. J. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0816 · Cited by 170
(1994) · PubMed Central · Cited by 169
Senile plaques in temporal lobe epilepsy
Mackenzie, I. R. A., & Miller, L. A. (1994) · Acta Neuropathologica · doi:10.1007/bf00294177 · Cited by 168
Kalman, J. L., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, Á., Boncz, I., Parry-Jones, W. L., & Janka, Z. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00275.x · Cited by 168
Das, S., & Potter, H. (1995) · Neuron · doi:10.1016/0896-6273(95)90300-3 · Cited by 167
?-Amyloid formation by myocytes of leptomeningeal vessels
Wisniewski, H. M., & Węgiel, J. (1994) · Acta Neuropathologica · doi:10.1007/bf00296738 · Cited by 165
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Cruz-Haces, M., TANG, J. C. Y., Acosta, G., Fernandez, J., & Shi, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0088-2 · Cited by 166
Sandbrink, R., Masters, C. L., & Beyreuther, K. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42286-1 · Cited by 163
Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme
Roßner, S., Lange‐Dohna, C., Zeitschel, U., & Perez-Polo, J. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02857.x · Cited by 174
Amyloidosis: a final common pathway for protein deposition in tissues
Stone, M. (1990) · Blood · doi:10.1182/blood.v75.3.531.531 · Cited by 160
Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain
Lütjohann, D., Brzezinka, A., Barth, E., Abramowski, D., Staufenbiel, M., von Bergmann, K., Beyreuther, K., Multhaup, G., & Bayer, T. A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200071-jlr200 · Cited by 158
Alzheimer's disease and post-operative cognitive dysfunction
Xie, Z., & Tanzi, R. E. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.014 · Cited by 159
Self-citationAntioxidant Therapy in Alzheimers Disease: Theory and Practice
Aliev, G., Obrenovich, M. E., Reddy, V. P., Shenk, J. C., Moreira, P. I., Nunomura, A., Zhu, X., Smith, M. A., & Perry, G. L. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369582 · Cited by 160
The synapse as a treatment avenue for Alzheimer’s Disease
Peng, L., Bestard‐Lorigados, I., & Song, W. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01565-z · Cited by 162
Guénette, S. Y., Chen, J., Jondro, P. D., & Tanzi, R. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10832 · Cited by 158
Self-citationEndogenous Proteins Controlling Amyloid β-Peptide Polymerization
Bohrmann, B., Tjernberg, L. O., Kuner, P., Poli, S. M., Levet‐Trafit, B., Näslund, J., Richards, G. J., Huber, W., Döbeli, H., & Nordstedt, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15990 · Cited by 158
Relationship between β-amyloid degradation and the 26S proteasome in neural cells
Salon, M. L., Pasquini, L. A., Moreno, M. B., Pasquini, J. M., & Soto, E. F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00060-2 · Cited by 161
Down syndrome and Alzheimer's disease: A link between development and aging
Lott, I. T., & Head, E. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1025 · Cited by 161
The molecular and genetic basis of AD: The end of the beginning
Rosenberg, R. N. (2000) · Neurology · doi:10.1212/wnl.54.11.2045 · Cited by 158
Nanomaterials for Drug Delivery to the Central Nervous System
Teleanu, D. M., Neguț, I., Grumezescu, V., Grumezescu, A. M., & Teleanu, R. I. (2019) · Nanomaterials · doi:10.3390/nano9030371 · Cited by 161
Tanaka, S., Shiojiri, S., Takahashi, Y., Kitaguchi, N., Ito, H., Kameyama, M., Kimura, J., Nakamura, S., & Ueda, K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92760-5 · Cited by 156
LeBlanc, A. C. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07837.1995 · Cited by 157
Tanaka, S., Nakamura, S., Ueda, K., Kameyama, M., Shiojiri, S., Takahashi, Y., Kitaguchi, N., & Ito, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80273-0 · Cited by 156
Regulated secretion of beta-amyloid precursor protein in rat brain
Farber, S., Nitsch, R. M., Schulz, J., & Wurtman, R. J. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07442.1995 · Cited by 155
Card, J. P., Meade, R. P., & Davis, L. G. (1988) · Neuron · doi:10.1016/0896-6273(88)90131-6 · Cited by 155
Hardy, J. (2017) · The FEBS Journal · doi:10.1111/febs.14004 · Cited by 153
Gorevic, P. D., Castaño, E. M., Sarma, R., & Frangione, B. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91008-4 · Cited by 153
Vitamin A and Alzheimer's disease
Ono, K., & Yamada, M. (2011) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00786.x · Cited by 156
Alifragis, P., & Marsh, J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230276 · Cited by 156
Complementary DNA for the mouse homolog of the human amyloid beta protein precursor
Yamada, T., Sasaki, H., Furuya, H., Miyata, T., Goto, I., & Sakaki, Y. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90419-0 · Cited by 151
Gajdusek, D. C. (1988) · Journal of Neuroimmunology · doi:10.1016/0165-5728(88)90140-3 · Cited by 151
Population-based family studies in genetic epidemiology
Hopper, J. L., Bishop, D. T., & Easton, D. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67570-8 · Cited by 150
Abraham, C. R., Shirahama, T., & Potter, H. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90045-2 · Cited by 150
Delaère, P., He, Y., Fayet, G., Duyckaerts, C., & Hauw, J.-J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90096-t · Cited by 149
Tomita, S., Ozaki, T., Taru, H., Oguchi, S., Takeda, S., Yagi, Y., Sakiyama, S., Kirino, Y., & Suzuki, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2243 · Cited by 148
Molecular genetics of Alzheimer's disease
Cruts, M., & Broeckhoven, C. V. (1998) · Annals of Medicine · doi:10.3109/07853899809002605 · Cited by 149
Potter, H. (1991) · Europe PMC (PubMed Central) · Cited by 147
Ohsawa, I., Takamura, C., Morimoto, T., Ishiguro, M., & Kohsaka, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00601.x · Cited by 147
Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease
Geller, L. N., & Potter, H. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0236 · Cited by 147
Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice
Masliah, E., Alford, M. F., Mallory, M. E., Rockenstein, E. M., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7386 · Cited by 148
Nostrand, W. E. V., Wagner, S. L., Farrow, J. S., & Cunningham, D. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38706-x · Cited by 144
Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells
Sambamurti, K., Shioi, J., Anderson, J. P., Pappolla, M. A., & Robakis, N. K. R. K. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330216 · Cited by 145
Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
Moncaster, J. A., Pineda, R., Moir, R. D., Lu, S., Burton, M. A., Ghosh, J. G., Ericsson, M., Soscia, S. J., Mocofanescu, A., Folkerth, R. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010659 · Cited by 142
Self-citationAmyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease.
Grundke, I., Iqbal, K., George, L., Tung, Y. C., Kim, K. S., & Wisniewski, H. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2853 · Cited by 142
Absence of Duplication of Chromosome 21 Genes in Familial and Sporadic Alzheimer's Disease
George‐Hyslop, P. S., Tanzi, R. E., Polinsky, R. J., Neve, R. L., Pollen, D. A., Drachman, D. A., Growdon, J. H., Cupples, L. A., Nee, L. E., Myers, R. H., et al. (1987) · Science · doi:10.1126/science.2890206 · Cited by 142
Self-citationPreliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis
Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141
Self-citationProteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Bayer, T. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.007 · Cited by 149
Selective ectodomain phosphorylation and regulated cleavage of beta‐amyloid precursor protein.
Hung, A. Y., & Selkoe, D. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06291.x · Cited by 141
Deposits of Amyloid β Protein in the Central Nervous System of Transgenic Mice
Wirak, D. O., Bayney, R. M., Ramabhadran, T. V., Fracasso, R. P., Hart, J., Hauer, P., Hsiau, P., Pekar, S. K., Scangos, G. A., Trapp, B. D., et al. (1991) · Science · doi:10.1126/science.1857970 · Cited by 141
Matsuda, S., Giliberto, L., Matsuda, Y., Davies, P., McGowan, E., Pickford, F., Ghiso, J., Frangione, B., & D'Adamio, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500217200 · Cited by 141
Ninomiya, H., Roch, J., Sundsmo, M. P., Otero, D. A., & Saitoh, T. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.4.879 · Cited by 140
Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.
Pasternack, J. M., Abraham, C. R., Dyke, B. J. V., Potter, H., & Younkin, S. G. (1989) · PubMed Central · Cited by 140
Benowitz, L. I., Rodriguez, W. R., Paskevich, P. A., Mufson, E. J., Schenk, D., & Neve, R. L. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90156-8 · Cited by 140
Self-citationBACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo
Lee, E. B., Zhang, B., Liu, K., Greenbaum, E. A., Doms, R. W., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200407070 · Cited by 140
The Amyloid β Protein Gene Is Not Duplicated in Brains from Patients with Alzheimer's Disease
Tanzi, R. E., Bird, E. D., Latt, S. A., & Neve, R. L. (1987) · Science · doi:10.1126/science.2890207 · Cited by 139
Self-citation
Metadata
- Authors
- Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L.
- Venue
- Science
- Published
- 1987-02-20
- Volume
- 235
- Issue
- 4791
- Pages
- 880-884
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2056046302
- Cited by
- 1,611
- References
- 41
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 14 · 2023: 22 · 2022: 19 · 2021: 23 · 2020: 33 · 2019: 31 · 2018: 18 · 2017: 27 · 2016: 29 · 2015: 22 · 2014: 22 · 2013: 33 · 2012: 34
- FWCI
- 123.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 00029)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 20118, HD10658)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- amyloid-beta, APP gene, Alzheimer's disease, Down syndrome, chromosome 21, genetic linkage, gene mapping, cerebrovascular amyloid, amyloid plaques, gene dosage
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Amyloid, Amyloidosis, Brain, Chromosome Mapping, Chromosomes, Human, Pair 21, DNA, Down Syndrome, Gene Expression Regulation, Humans, Genetic Linkage, RNA, Messenger, Tissue Distribution, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review